The A 3 agonist 2-CI-IB-MECA [0.5 mM] increased the mean amplitude of the a-wave (91.4±15.4 µV to 152.9±21.2 µV; p = 0.006), while causing a decrease in the mean amplitude of the b-waves of both dark adapted (290.9±40.3 µV to 210±21.4 µV; p = 0.022) and light adapted (170±19 µV to 135.9±11.4 µV; p = 0.037) eyes.
A 3 samverkarinn 2-Cl-IB-MECA [0.5 mM] olli aukningu í meðal spennuvídd a-bylgju (91.4±15.4 µV í 152.9±21.2 µV; p = 0.006). Hann minnkaði meðal spennuvídd b-bylgju, bæði í rökkursaðlögðum (290.9±40.3 µV í 210±21.4 µV; p = 0.022) og ljósaðlöguðum 170±19 µV í 135.9±11.4 µV; p = 0.037) augum.